Lab
Microgendx, LLC
Microgendx, LLC was paid $2.11M by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 21% of everything it billed.
33Billing provider infoMICROGENDX, LLC
LUBBOCK, TX 79413
LUBBOCK, TX 79413
33aNPI1073776860assigned 07/02/2008
33bProvider typeClinical Medical Laboratory
28Total paid$2.11M
24GClaims147,001
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#41 of 436
Median peer was paid$17K
This provider vs. median122×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,567 | $325K | |
| 2019 | 28,827 | $307K | |
| 2020 | 31,683 | $576K | |
| 2021 | 29,908 | $559K | |
| 2022 | 27,559 | $287K | |
| 2023 | 2,385 | $49K | |
| 2024incomplete | 1,072 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 21% | 6,737 | 5,955 | $448K |
| 87799 | 11% | 25,272 | 8,928 | $238K | |
| 87900 | 10% | 7,098 | 6,189 | $218K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 8.0% | 10,319 | 9,125 | $168K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7.9% | 17,487 | 4,713 | $167K |
| 87640 | 6.6% | 14,446 | 12,581 | $138K | |
| 87653 | 6.2% | 14,825 | 12,823 | $131K | |
| 87500 | 3.2% | 7,123 | 6,085 | $68K | |
| 87482 | 3.2% | 5,617 | 4,885 | $67K | |
| 87481 | 3.2% | 8,047 | 6,982 | $67K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.0% | 416 | 332 | $62K |
| 0112U | 2.5% | 3,739 | 3,413 | $53K |
22 more codes
| 87512 | 2.5% | 4,530 | $53K | |
| 87652 | 2.2% | 5,157 | $47K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 3,248 | $30K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.2% | 158 | $26K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,717 | $21K |
| 87641 | <1% | 2,550 | $20K | |
| 87492 | <1% | 1,481 | $18K | |
| 87592 | <1% | 1,477 | $17K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,498 | $16K |
| 87511 | <1% | 1,329 | $11K | |
| 87507 | <1% | 26 | $7K | |
| 87581 | <1% | 357 | $5K | |
| 87486 | <1% | 357 | $5K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 1,422 | $3K |
| 87631 | <1% | 34 | $2K | |
| 87563 | <1% | 311 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | $574.84 |
| 87634 | <1% | 15 | $363.98 | |
| 89051 | <1% | 94 | $88.40 | |
| 89060 | <1% | 18 | $51.97 | |
| 86140 | <1% | 63 | $35.91 | |
| 83872 | <1% | 18 | $26.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLLINS, SHANLEY (BILLING MANAGER)